Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Nucleosides & Nucleotides
|
August 5, 1999
Methylenecyclopropane analogues of nucleosides: synthesis, absolute configuration, and enantioselectivity of antiviral effect of (R)-(-)- and (S)-(+)-synadenol
Y L Qiu, A Hempel, N Camerman, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
(R)-(-)- and (S)-(+)-Synadenol: synthesis, absolute configuration, and enantioselectivity of antiviral effect
Y L Qiu, A Hempel, N Camerman, et al.
The Journal of Biological Chemistry
|
March 1, 2015
Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein
Erez Pery, Ann Sheehy, N Miranda Nebane, et al.
Antimicrobial Agents and Chemotherapy
|
March 5, 2008
Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides
Carol Lackman-Smith, Clay Osterling, Katherine Luckenbaugh, et al.
AIDS Research and Human Retroviruses
|
November 26, 2008
Cataloguing the HIV type 1 human protein interaction network
Roger G Ptak, William Fu, Brigitte E Sanders-Beer, et al.
Antiviral Research
|
November 10, 2016
An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation
Ryan P Bennett, Ryan A Stewart, Priscilla A Hogan, et al.
The Journal of Biological Chemistry
|
October 4, 2005
Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells
Udayan Chatterji, Michael D Bobardt, Robyn Stanfield, et al.
Plos Pathogens
|
October 15, 2019
Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals
Elizabeth R Wonderlich, Krupa Subramanian, Bryan Cox, et al.
The Journal of Biological Chemistry
|
September 24, 2008
Albumin-conjugated C34 peptide HIV-1 fusion inhibitor: equipotent to C34 and T-20 in vitro with sustained activity in SCID-hu Thy/Liv mice
Cheryl A Stoddart, Geneviève Nault, Sofiya A Galkina, et al.
Antiviral Research
|
March 12, 2010
In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor
H Javanbakht, R G Ptak, E Chow, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Nucleosides & Nucleotides
|
August 5, 1999
Methylenecyclopropane analogues of nucleosides: synthesis, absolute configuration, and enantioselectivity of antiviral effect of (R)-(-)- and (S)-(+)-synadenol
Y L Qiu, A Hempel, N Camerman, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
(R)-(-)- and (S)-(+)-Synadenol: synthesis, absolute configuration, and enantioselectivity of antiviral effect
Y L Qiu, A Hempel, N Camerman, et al.
The Journal of Biological Chemistry
|
March 1, 2015
Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein
Erez Pery, Ann Sheehy, N Miranda Nebane, et al.
Antimicrobial Agents and Chemotherapy
|
March 5, 2008
Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides
Carol Lackman-Smith, Clay Osterling, Katherine Luckenbaugh, et al.
AIDS Research and Human Retroviruses
|
November 26, 2008
Cataloguing the HIV type 1 human protein interaction network
Roger G Ptak, William Fu, Brigitte E Sanders-Beer, et al.
Antiviral Research
|
November 10, 2016
An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation
Ryan P Bennett, Ryan A Stewart, Priscilla A Hogan, et al.
The Journal of Biological Chemistry
|
October 4, 2005
Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells
Udayan Chatterji, Michael D Bobardt, Robyn Stanfield, et al.
Plos Pathogens
|
October 15, 2019
Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals
Elizabeth R Wonderlich, Krupa Subramanian, Bryan Cox, et al.
The Journal of Biological Chemistry
|
September 24, 2008
Albumin-conjugated C34 peptide HIV-1 fusion inhibitor: equipotent to C34 and T-20 in vitro with sustained activity in SCID-hu Thy/Liv mice
Cheryl A Stoddart, Geneviève Nault, Sofiya A Galkina, et al.
Antiviral Research
|
March 12, 2010
In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor
H Javanbakht, R G Ptak, E Chow, et al.
Page
of 9